AMIVF(AMIVF)
AMIVF
No analyst ratings available
No analyst price targets available for AMIVF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $82M | $84M |
| Low | $82M | $81M |
| High | $82M | $87M |
| EBITDA Avg | $70M | $72M |
| Low | $70M | $69M |
| High | $70M | $74M |
| EBIT Avg | $70M | $72M |
| Low | $70M | $69M |
| High | $70M | $74M |
| Net Income Avg | $40M | $40M |
| Low | $39M | $39M |
| High | $41M | $41M |
| EPS Avg | $1.00 | $1.01 |
| Low | $0.98 | $0.98 |
| High | $1.03 | $1.03 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $20M | $21M | $20M | $20M | $20M | $20M |
| Low | $20M | $21M | $20M | $20M | $20M | $20M |
| High | $20M | $21M | $20M | $20M | $20M | $20M |
| EBITDA Avg | $17M | $18M | $17M | $17M | $17M | $17M |
| Low | $17M | $18M | $17M | $17M | $17M | $17M |
| High | $17M | $18M | $17M | $17M | $17M | $17M |
| EBIT Avg | $17M | $18M | $17M | $17M | $17M | $17M |
| Low | $17M | $18M | $17M | $17M | $17M | $17M |
| High | $17M | $18M | $17M | $17M | $17M | $17M |
| Net Income Avg | $9M | $9M | $9M | $9M | $10M | $10M |
| Low | $9M | $9M | $9M | $9M | $10M | $10M |
| High | $9M | $9M | $9M | $9M | $10M | $10M |
| EPS Avg | $0.25 | $0.25 | $0.25 | $0.25 | $0.26 | $0.26 |
| Low | $0.25 | $0.25 | $0.25 | $0.25 | $0.26 | $0.26 |
| High | $0.25 | $0.25 | $0.25 | $0.25 | $0.26 | $0.26 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |